1. Home
  2. RGEN vs LW Comparison

RGEN vs LW Comparison

Compare RGEN & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LW
  • Stock Information
  • Founded
  • RGEN 1981
  • LW 1950
  • Country
  • RGEN United States
  • LW United States
  • Employees
  • RGEN N/A
  • LW N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LW Packaged Foods
  • Sector
  • RGEN Health Care
  • LW Consumer Staples
  • Exchange
  • RGEN Nasdaq
  • LW Nasdaq
  • Market Cap
  • RGEN 7.4B
  • LW 7.3B
  • IPO Year
  • RGEN N/A
  • LW N/A
  • Fundamental
  • Price
  • RGEN $127.85
  • LW $51.44
  • Analyst Decision
  • RGEN Buy
  • LW Buy
  • Analyst Count
  • RGEN 12
  • LW 12
  • Target Price
  • RGEN $172.67
  • LW $72.17
  • AVG Volume (30 Days)
  • RGEN 856.4K
  • LW 1.6M
  • Earning Date
  • RGEN 04-29-2025
  • LW 04-03-2025
  • Dividend Yield
  • RGEN N/A
  • LW 2.87%
  • EPS Growth
  • RGEN N/A
  • LW N/A
  • EPS
  • RGEN N/A
  • LW 2.55
  • Revenue
  • RGEN $650,429,000.00
  • LW $6,387,400,000.00
  • Revenue This Year
  • RGEN $12.61
  • LW $1.32
  • Revenue Next Year
  • RGEN $15.24
  • LW $1.19
  • P/E Ratio
  • RGEN N/A
  • LW $20.24
  • Revenue Growth
  • RGEN 4.88
  • LW N/A
  • 52 Week Low
  • RGEN $102.97
  • LW $47.90
  • 52 Week High
  • RGEN $182.52
  • LW $89.51
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 42.92
  • LW 43.75
  • Support Level
  • RGEN $125.31
  • LW $51.01
  • Resistance Level
  • RGEN $143.56
  • LW $51.97
  • Average True Range (ATR)
  • RGEN 6.86
  • LW 1.33
  • MACD
  • RGEN -0.68
  • LW -0.13
  • Stochastic Oscillator
  • RGEN 11.72
  • LW 38.32

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: